(0.14%) 5 529.00 points
(0.17%) 39 535 points
(0.08%) 19 943 points
(0.45%) $81.91
(-1.19%) $2.57
(0.10%) $2 341.90
(-0.03%) $29.55
(-1.83%) $995.50
(-0.31%) $0.930
(-0.36%) $10.64
(-0.19%) $0.789
(1.98%) $87.43
-1.14% $ 33.03
Live Chart Being Loaded With Signals
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology...
Stats | |
---|---|
Объем за сегодня | 5 163 |
Средний объем | 88 438 |
Рыночная капитализация | 71.78B |
EPS | $1.600 ( Q1 | 2024-03-31 ) |
Дата следующего отчета о доходах | ( $0.440 ) 2024-08-01 |
Last Dividend | $0.472 ( 2023-05-02 ) |
Next Dividend | $0 ( N/A ) |
P/E |
24.65 (Sector) 0 (Industry) 0 |
ATR14 | $0.0520 (0.16%) |
Объем Корреляция
MERCK Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
MERCK Корреляция - Валюта/Сырье
MERCK Финансовые показатели
Annual | 2023 |
Выручка: | $20.99B |
Валовая прибыль: | $11.67B (55.59 %) |
EPS: | $6.50 |
FY | 2023 |
Выручка: | $20.99B |
Валовая прибыль: | $11.67B (55.59 %) |
EPS: | $6.50 |
FY | 2022 |
Выручка: | $22.23B |
Валовая прибыль: | $13.71B (61.65 %) |
EPS: | $7.65 |
FY | 2021 |
Выручка: | $19.69B |
Валовая прибыль: | $12.34B (62.66 %) |
EPS: | $1.405 |
Financial Reports:
No articles found.
MERCK Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.472 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.505 | 2008-03-26 |
Last Dividend | $0.472 | 2023-05-02 |
Next Dividend | $0 | N/A |
Payout Date | 2023-05-11 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | $4.47 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.25 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.57 | |
Div. Directional Score | 8.62 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
02 May 2023 | $0.472 | 01 Aug 2023 | 03 May 2023 | 11 May 2023 |
25 Apr 2022 | $0.392 | 30 Nov -0001 | 30 Nov -0001 | 04 May 2022 |
26 Apr 2021 | $0.334 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 Jun 2020 | $0.284 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
29 Apr 2019 | $0.283 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 May 2018 | $0.307 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 May 2017 | $0.255 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
27 Apr 2016 | $0.234 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
15 Apr 2015 | $0.220 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
07 May 2014 | $0.262 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
24 Apr 2013 | $0.221 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
18 Apr 2012 | $0.196 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
06 Apr 2011 | $0.176 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
07 Apr 2010 | $0.134 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 Apr 2009 | $0.191 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
26 Mar 2008 | $0.505 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SPKKY | Ex Dividend Knight | 2023-09-14 | Annually | 0 | 0.00% | |
CSHX | Ex Dividend Junior | 2023-07-27 | Semi-Annually | 0 | 0.00% | |
NHMD | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
AYALY | Ex Dividend Junior | 2023-07-28 | Semi-Annually | 0 | 0.00% | |
ILKAY | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
UEPCP | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
EXSR | Ex Dividend Knight | 2023-08-31 | Quarterly | 0 | 0.00% | |
PTBS | Ex Dividend Knight | 2023-08-03 | Quarterly | 0 | 0.00% | |
CHRYY | Ex Dividend Knight | 2023-09-08 | Annually | 0 | 0.00% | |
LNNGY | Ex Dividend Knight | 2023-08-23 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.131 | 1.500 | 7.38 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0550 | 1.200 | 8.17 | 9.80 | [0 - 0.3] |
returnOnEquityTTM | 0.0994 | 1.500 | -0.00688 | -0.0103 | [0.1 - 1] |
payoutRatioTTM | 0.442 | -1.000 | 5.58 | -5.58 | [0 - 1] |
currentRatioTTM | 1.290 | 0.800 | 8.55 | 6.84 | [1 - 3] |
quickRatioTTM | 0.721 | 0.800 | -0.465 | -0.372 | [0.8 - 2.5] |
cashRatioTTM | 0.223 | 1.500 | 9.87 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.201 | -1.500 | 6.65 | -9.97 | [0 - 0.6] |
interestCoverageTTM | 11.14 | 1.000 | 6.98 | 6.98 | [3 - 30] |
operatingCashFlowPerShareTTM | 9.12 | 2.00 | 6.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.20 | 2.00 | 7.90 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.356 | -1.500 | 8.58 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.580 | 1.000 | 3.66 | 3.66 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.185 | 1.000 | 8.30 | 8.30 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.398 | 1.000 | 8.90 | 8.90 | [0.2 - 2] |
assetTurnoverTTM | 0.421 | 0.800 | -0.530 | -0.424 | [0.5 - 2] |
Total Score | 10.67 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.90 | 1.000 | 9.61 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0994 | 2.50 | -0.00443 | -0.0103 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.20 | 2.00 | 8.60 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.659 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 9.12 | 2.00 | 6.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.442 | 1.500 | 5.58 | -5.58 | [0 - 1] |
pegRatioTTM | 0.748 | 1.500 | 8.34 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.190 | 1.000 | 7.74 | 0 | [0.1 - 0.5] |
Total Score | 6.57 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
MERCK
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа